These data validated the immunosuppressive role of MARCO+ TAMs, which facilitate immune escape via significantly hindering the activation of the CD8+ T cells, highlighting the importance of MARCO‐targeted therapy in the restoring of anti‐tumor immunity. The gene discussed is CD8A; the disease is neoplasm.